A three-month treatment window provides enough time to assess your body's response, adjust your dose as needed, and establish sustainable habits alongside medication therapy
Key outcomes: body weight
No issue giving the injection
While research is ongoing to determine why GLP-1s like Mounjaro may put patients at an increased risk of developing blood clots, potential mechanisms include the higher incidence of diarrhea and dehydration associated with the use of the drug, leading to increased blood viscosity
From the first meeting to your first injection, we focus on your comfort at every step
In addition to Se as the main regulator of GPx1 expression, the factors associating the selenocysteine insertion sequence (SECIS), adenosine [33], c-Abl and Arg tyrosine kinase receptors, and epidermal growth factor influence gene expression of GPx1 and affect the functional coordination between GPx1 and other selenoproteins or antioxidant enzymes in various metabolic circumstances